Navigation Links
Understanding HIV Interference With Infected Cell Division

Montreal, July 12, 2007 Dr. Eric A. Cohen, a researcher at the IRCM (Institut de recherches cliniques de Montreal), and his team will publish on Friday, July 13, in PLoS Pathogens a discovery that could lead to the development of a new class of drugs to combat HIV.

Human immunodeficiency virus type 1 (HIV-1) causes AIDS by depleting essential immune cells called CD4+T lymphocytes in infected individuals, resulting in a compromised immune system. At the center of this process is the HIV protein, viral protein R (Vpr), which stops infected CD4+T cells from dividing and as a consequence compromises their immune function.

In addition, by arresting cell division, Vpr helps HIV to harness the infected cells resources to enhance viral replication. The way Vpr exerts this effect is by interacting with cellular proteins that control cell division.

Dr. Cohen and his team have identified a novel cellular protein complex targeted by HIV-1 Vpr to stop infected cell division. This protein complex, designated DDB1-CUL4-VprBP, is involved in a process called ubiquitination.

Ubiquitination is a mechanism by which a small protein called ubiquitin is conjugated to cellular proteins in order to modulate their biological activity or induce their degradation.

The researchers demonstrated that association of Vpr with this ubiquitinating complex, also called an E3 ubiquitin ligase complex, is essential for the defect in cell division induced by Vpr. Further characterization of this protein complex as well as the elucidation of the mechanism by which it affects cell division may open new avenues for therapeutic intervention against HIV.




'"/>




Page: 1

Related medicine news :

1. Understanding The Predictors Of Prostate Cancer
2. Understanding Restless Legs Syndrome
3. Understanding Lung Cancer Metastasis
4. Understanding The Link Between Hormone Replacement and Respiratory Disease
5. Understanding The Risks Of Hormone Therapy
6. Understanding The Link Between Metabolic Syndrome And Drinking Patterns
7. A Better Understanding Of The Brain Network
8. Understanding The Predictor’s Of Alzheimer’s Diseae
9. Understanding The Harmful Effects Of Radiation Exposure
10. Understanding The Origin Of Tumors
11. Understanding Insulin Resistance

Post Your Comments:
(Date:12/2/2009)... , Fruit flies may seem like unlikely heroes in t...gests that these insects already used to study do...ntists are reporting that fruit flies can be used ...studying the effects of cocaine and other drugs of... ACS Chemical Neuroscience , a new monthly journa...
(Date:12/2/2009)... SALT LAKE CITYHow do fruit flies get high choles... by eating a diet that,s too rich in fats. , Mor... a University of Utah human geneticist, fruit flie...elp maintain proper balances of cholesterol and a .... The findings mean that as researchers try to lea...
(Date:12/2/2009)... ILS Technology and ASML ... Boca Raton, Fla. (PRWEB) December 2...in enabling intelligence through connectivity, tod...customer were both recognized with awards for tech...ber 7th at ISAexpo, the International Society of A...
(Date:12/2/2009)..., , WASHINGTON, Dec. 2 Hol...nal Media and Stakeholder Management for Kaiser Pe...PR News, PR People luncheon held at the National ...mpetition showcases the top innovators and profess...tions matter in the marketplace. The winners of th...
(Date:12/2/2009)..., , SAN DIEGO, Dec. 2 /PRNewswire-Firs...versified supplier of Farming, Nursery and Wellnes...casing its Aloe365(TM) products at the Cook,sware ...December 11-20, 2009. ,, For additional informa...rtment at 877-90-FARMS or visit http://cookswarea...
Breaking Medicine News(10 mins):Health News:Latest epidemic? High cholesterol, obesity in fruit flies 2Health News:Latest epidemic? High cholesterol, obesity in fruit flies 3Health News:ILS Technology and Customer ASML Recipients of Industry Recognition Awards 2Health News:Kaiser Permanente Public Relations Leader Wins PR People Award 2Health News:Kaiser Permanente Public Relations Leader Wins PR People Award 3Health News:US Farms, Inc. Showcasing Aloe365(TM) Product Line at Cook'sware A'faire at Oakland Zoo 2
...s at $4 billion, similar to asthma , , MON...nited States, treatment of childhood constipation ...ma and attention-deficit hyperactivity disorder (A...8 who were diagnosed with constipation or prescrib...
...ockefeller Foundation, New York State Health Found...und, Prudential Social Investment Program and the ...ation Among Investors to Join Leading Advocate for... NEW YORK (Business Wire EON) December 8, 2008...
...Care and Associated Surgical & Medical Special... centers, announced today that they have entered i...ntly operate the surgery center in Franklin. , ...r patients," said James Barton, M.D., an otolaryng...
...ells from cell death and exerts resistance to chem...t can be exploited to target and kill the very tum... University of Illinois at Chicago show in a new s...cers. , "Akt is perhaps the most frequently acti...
...patients who have a poor relationship with their s...han would other women, according to a new study. ,...s in distressed marriages had higher levels of str...lity of the marital relationship may not be the fi...
... Toxic Air Pollution While EPA Shirks Responsibili...g USA TODAY released their study of schools where ...from chemical contamination to young children and ... (CHEJ) has been reporting since 2001. In several...
Other Medicine News:Health News:Childhood Constipation Carries a Big Price Tag 2Health News: Prominent Philanthropies and Businesses Join Freelancers Union to Pioneer New Health Insurance Model 2Health News: Prominent Philanthropies and Businesses Join Freelancers Union to Pioneer New Health Insurance Model 3Health News: Prominent Philanthropies and Businesses Join Freelancers Union to Pioneer New Health Insurance Model 4Health News: Prominent Philanthropies and Businesses Join Freelancers Union to Pioneer New Health Insurance Model 5Health News:Aurora and Associated Surgical & Medical Specialists Announce Surgery Center Joint Venture 2Health News:An Achilles heel in cancer cells 2Health News:Marital problems lead to poorer outcomes for breast cancer patients 2Health News:Marital problems lead to poorer outcomes for breast cancer patients 3Health News:If Your Child Says School Makes Him Sick - He Might Be Right 2
(Date:12/2/2009)...r 2 Cardio Vascular,Medi... advanced,cardiovascular surgery technology, today...pproved a one-for-three forward stock split, in th...ular Medical Device shareholders. , The C...ate the stock,split will be payable and the relate...
(Date:12/2/2009)...RNewswire-FirstCall/ -- PDL BioPharma, Inc. (PDL) ...lished the per share amount of the previously anno...hare. The dividend will be paid on December 15, 20... December 1, 2009 record date. NASDAQ had previous...he dividend at $1.67 per share of common stock for...
(Date:12/2/2009)...ewswire-FirstCall/ -- Roche (SIX: RO, ROG; OTCQX: ... & Drug Administration (FDA) approved an addit...est, to screen source plasma in pools comprised of...he cobas® TaqScreen MPX Test for use on the ...st for the simultaneous, direct detection of the h...
Breaking Medicine Technology:Cardio Vascular Medical Device Announces Forward Stock Split 2PDL BioPharma Announces December 15 Special Dividend Payment of $1.67 per Share 2PDL BioPharma Announces December 15 Special Dividend Payment of $1.67 per Share 3FDA Approves Use of Roche Test to Screen Source Plasma for HIV, Hepatitis B Virus and Hepatitis C Virus 2FDA Approves Use of Roche Test to Screen Source Plasma for HIV, Hepatitis B Virus and Hepatitis C Virus 3Portola Pharmaceuticals to Host Conference Call at 11 3A00 a m Eastern Time Tomorrow to Discuss Betrixaban Partnership and Provide Corporate Update 51112 1Portola Pharmaceuticals to Host Conference Call at 11 3A00 a m Eastern Time Tomorrow to Discuss Betrixaban Partnership and Provide Corporate Update 51112 2Post transplant combo can replace toxic immune suppressing drugs in monkeys 51106 1Post transplant combo can replace toxic immune suppressing drugs in monkeys 51106 2Springer launches SpringerImages 9172 1Springer launches SpringerImages 9172 2
...ts from Phase 1 Studies with Monoclonal Antibody,T...ovide Further,Rationale for IL-9 Inhibition in Dev...Md., May 24, 2007 /PRNewswire-FirstCall/ --,MedImm...,highlighting recent progress within the company,s...from two Phase 1 clinical,studies with its monoclo...
..., May 25, 2007 /PRNewswire/ -- With enormous,inves... at play,pharmaceutical firms need to develop eff... results early. Companies that master,their commun...cant,advantage in the marketplace. , According to ...successful companies create communication plans lo...
Other Medicine Technology:MedImmune Highlights Advances in Inflammatory Disease Pipeline With,Series of Data Presentations 2MedImmune Highlights Advances in Inflammatory Disease Pipeline With,Series of Data Presentations 3MedImmune Highlights Advances in Inflammatory Disease Pipeline With,Series of Data Presentations 4MedImmune Highlights Advances in Inflammatory Disease Pipeline With,Series of Data Presentations 5MedImmune Highlights Advances in Inflammatory Disease Pipeline With,Series of Data Presentations 6MedImmune Highlights Advances in Inflammatory Disease Pipeline With,Series of Data Presentations 7Clinical Trial Excellence: Shaping Markets Through Early,Communication of Clinical Trial Data 2Clinical Trial Excellence: Shaping Markets Through Early,Communication of Clinical Trial Data 3
Seldin Periosteal Elevators
Williger Periosteal Elevators
Modified Freer Periosteal Elevator #163
Steinhauser Periosteal Elevator
Medicine Products: